Rankings
▼
Calendar
KMDA Q4 2019 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q4 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$32M
-33.5% YoY
Gross Profit
$12M
37.7% margin
Operating Income
$5M
17.1% margin
Net Income
$5M
16.7% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
-3.0%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$8M
Stock-Based Comp.
$176,000
Balance Sheet
Total Assets
$174M
Total Liabilities
$38M
Stockholders' Equity
$135M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$32M
$48M
-33.5%
Gross Profit
$12M
$21M
-43.1%
Operating Income
$5M
$15M
-64.3%
Net Income
$5M
$18M
-69.8%
← FY 2019
All Quarters
Q1 2020 →